Furthermore, the multivariate analysis in the pure DCIS series with IBC recurrence also demonstrated that low RECQL expression was an independent prognostic factor for tumor recurrence in patients treated with BCS (p = 0.029; HR = 2.913; 95 % CI = 1115–7.608). This evidence concerns the gene RECQL and neoplasm.